2023

M

María-Jesús Lobón-Iglesias et al.
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-42371-7

Antía Figueroa-Romero et al.
Prevalence of molecular markers of resistance to sulfadoxine–pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation
The Lancet Global Health 2023, vol. 11, issue 11
doi: 10.1016/s2214-109x(23)00414-x

Emma Bergsten et al.
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes
Gut Microbes 2023, vol. 15, issue 2
doi: 10.1080/19490976.2023.2265138

Selene E. Di Carlo et al.
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
Nature Immunology 2023, vol. 24, issue 11
doi: 10.1038/s41590-023-01642-7

Selam Mihreteab et al.
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
New England Journal of Medicine 2023, vol. 389, issue 13
doi: 10.1056/nejmoa2210956

M

Wenwen Gao et al.
Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity
Nature Metabolism 2023, vol. 5, issue 10
doi: 10.1038/s42255-023-00889-6

M

Domenico Iuso et al.
Nucleoside diphosphate kinases 1 and 2 regulate a protective liver response to a high-fat diet
Science Advances 2023, vol. 9, issue 36
doi: 10.1126/sciadv.adh0140

M

et al.
A second update on mapping the human genetic architecture of COVID-19
Nature 2023, vol. 621, issue 7977
doi: 10.1038/s41586-023-06355-3

M

Salomé Decombis et al.
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
Blood 2023, vol. 142, issue 18
doi: 10.1182/blood.2023020211

Marion Thibaudin et al.
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
Nature Medicine 2023, vol. 29, issue 8
doi: 10.1038/s41591-023-02497-z